Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation
Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation
Active, not recruiting · NCT07725432 · Registry updated 2026-07-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topical Ruxolitinib Evaluation in Immune-related Vitiligo-like Depigmentation | Lichenoid Eruptions, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, hypopigmentation of the skin, lichen sclerosus et atrophicus, skin disorder, skin pigmentation disorder, vitiligo | Active, not recruiting | Phase 2 | 2026-07-24 | NCT07725432 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Zurich | 188 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Universitätsspital Zürich | Zurich | Switzerland | 1 |